Stephen Bevan Shrewsbury

Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.

Stephen Bevan Shrewsbury

Stephen Bevan Shrewsbury

Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.

Overview
RelSci Relationships

895

Number of Boards

2

Birthday

1957

Age

63

Relationships
RelSci Relationships are individuals Stephen Bevan Shrewsbury likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Gurnet Point Capital LLC

Relationship likelihood: Strong

Executive Chairman at PDS Operating Corp.

Relationship likelihood: Strong

Chief Medical Officer at SetPoint Medical Corp.

Relationship likelihood: Strong

Operating Partner at Advent International LLC

Relationship likelihood: Strong

Managing Partner at Wellington Partners GmbH

Relationship likelihood: Strong

Executive Officer at The University of North Carolina at Chapel Hill

Relationship likelihood: Strong

Associate at Biométhodes SA

Relationship likelihood: Strong

Director & Chief Scientific Officer at Jupiter Orphan Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Autifony Therapeutics Ltd.

Relationship likelihood: Strong

Chairman, North America New Member Recruitment Task Force at International Trademark Association, Inc.

Relationship likelihood: Strong

Paths to Stephen Bevan Shrewsbury
Potential Connections via
Relationship Science
You
Stephen Bevan Shrewsbury
Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.
Education
Bachelor of Medicine Degree

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Career History
Head-Senior Clinical Program
1993 - 2002

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Chief Medical Officer & Senior Vice President-Preclinical
2009 - 2011

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Senior Director-Clinical Development
2002 - 2005

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Boards & Committees
Director
Current
Director
1993 - 2002

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen Bevan Shrewsbury. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen Bevan Shrewsbury's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen Bevan Shrewsbury.